NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 7th Jan 2026 NOVO-B STOCK Price closed @ 366.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 364.00 Change Price %
High 369.20 1 Day 2.35 0.65
Low 357.30 1 Week 62.90 20.72
Close 366.40 1 Month 55.75 17.95
Volume 7585852 1 Year -381.20 -50.99
52 Week High 790.30 | 52 Week Low 287.00
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 366.40 0.65%
CONFRZ 0.02 0.00%
VWS 186.00 -0.69%
VJBA 7.33 0.41%
DANSKE 314.00 -1.66%
ORSTED 133.20 0.57%
ALMB 18.07 -3.06%
SHAPE 5.03 30.65%
TRYG 159.70 -2.32%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
LEDIBOND 0.04 33.33%
SHAPE 5.03 30.65%
FASTPC 22.80 30.29%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
GRLA 1100.00 15.79%
SAME 1.45 10.69%
SAME 1.45 10.69%
AQP 1.40 9.38%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
BO 12.06 -12.48%
BO 12.06 -12.48%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE389.33
RESISTANCE381.98
RESISTANCE377.43
RESISTANCE372.89
SUPPORT359.91
SUPPORT355.37
SUPPORT350.82
SUPPORT343.47
 
NOVO-B Forecast January 2026
4th UP Forecast890.74
3rd UP Forecast722.58
2nd UP Forecast618.64
1st UP Forecast514.69
1st DOWN Forecast218.11
2nd DOWN Forecast114.16
3rd DOWN Forecast10.22
4th DOWN Forecast-157.94
 
NOVO-B Weekly Forecast
4th UP Forecast437.70
3rd UP Forecast414.83
2nd UP Forecast400.70
1st UP Forecast386.57
1st DOWN Forecast346.24
2nd DOWN Forecast332.10
3rd DOWN Forecast317.97
4th DOWN Forecast295.10
 
NOVO-B Forecast2026
4th UP Forecast1390.02
3rd UP Forecast1061.74
2nd UP Forecast858.82
1st UP Forecast655.9
1st DOWN Forecast76.9
2nd DOWN Forecast-126.02
3rd DOWN Forecast-328.94
4th DOWN Forecast-657.22
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service